FOTIVDA is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Aveo Pharmaceuticals, Inc.. The primary component is Tivozanib Hydrochloride.
Product ID | 45629-134_22d362c3-0746-49c4-8109-6f30bfc86cb8 |
NDC | 45629-134 |
Product Type | Human Prescription Drug |
Proprietary Name | FOTIVDA |
Generic Name | Tivozanib |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2021-03-10 |
Marketing Category | NDA / |
Application Number | NDA212904 |
Labeler Name | AVEO Pharmaceuticals, Inc. |
Substance Name | TIVOZANIB HYDROCHLORIDE |
Active Ingredient Strength | 1 mg/1 |
Pharm Classes | Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2021-03-10 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
45629-089 | FOTIVDA | Tivozanib |
45629-134 | FOTIVDA | Tivozanib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() FOTIVDA 86580973 4984746 Live/Registered |
AVEO Pharmaceuticals, Inc. 2015-03-30 |
![]() FOTIVDA 85430468 not registered Dead/Abandoned |
AVEO Pharmaceuticals, Inc. 2011-09-23 |